rs56284940
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001318895.3(FHL2):c.85G>A(p.Val29Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00149 in 1,614,228 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V29A) has been classified as Uncertain significance.
Frequency
Consequence
NM_001318895.3 missense
Scores
Clinical Significance
Conservation
Publications
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000992 AC: 151AN: 152220Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00109 AC: 274AN: 251470 AF XY: 0.00129 show subpopulations
GnomAD4 exome AF: 0.00154 AC: 2250AN: 1461890Hom.: 5 Cov.: 31 AF XY: 0.00167 AC XY: 1213AN XY: 727246 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000991 AC: 151AN: 152338Hom.: 1 Cov.: 32 AF XY: 0.000819 AC XY: 61AN XY: 74494 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:1
proposed classification - variant undergoing re-assessment, contact laboratory -
Cardiomyopathy Benign:1
- -
Primary dilated cardiomyopathy Benign:1
- -
FHL2-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at